JAFL
IBB icon

Jay A. Fishman Ltd’s iShares Biotechnology ETF IBB Stock Holding History

Jay A. Fishman Ltd’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,940
Closed -$372K – 82
2025
Q2 		$372K Hold
2,940
– – 0.04% 70
2025
Q1 		$376K Hold
2,940
– – 0.04% 70
2024
Q4 		$389K Hold
2,940
– – 0.04% 76
2024
Q3 		$428K Hold
2,940
– – 0.04% 72
2024
Q2 		$404K Hold
2,940
– – 0.04% 70
2024
Q1 		$403K Hold
2,940
– – 0.04% 72
2023
Q4 		$399K Hold
2,940
– – 0.05% 73
2023
Q3 		$360K Hold
2,940
– – 0.05% 73
2023
Q2 		$373K Hold
2,940
– – 0.05% 77
2023
Q1 		$380K Hold
2,940
– – 0.05% 74
2022
Q4 		$386K Hold
2,940
– – 0.05% 74
2022
Q3 		$344K Hold
2,940
– – 0.05% 77
2022
Q2 		$346K Hold
2,940
– – 0.05% 77
2022
Q1 		$383K Sell
2,940
-100
-3% -$13K 0.04% 79
2021
Q4 		$464K Hold
3,040
– – 0.05% 75
2021
Q3 		$492K Hold
3,040
– – 0.06% 68
2021
Q2 		$497K Hold
3,040
– – 0.06% 68
2021
Q1 		$458K Sell
3,040
-60
-2% -$9.53K 0.06% 73
2020
Q4 		$470K Buy
3,100
+160
+5% +$22.9K 0.06% 68
2020
Q3 		$398K Hold
2,940
– – 0.06% 68
2020
Q2 		$402K Sell
2,940
-2,940
-50% -$375K 0.07% 64
2020
Q1 		$645K Buy
5,880
+2,940
+100% +$338K 0.07% 73
2019
Q4 		$354K Hold
2,940
– – 0.06% 72
2019
Q3 		$293K Hold
2,940
– – 0.05% 71
2019
Q2 		$321K Hold
2,940
– – 0.06% 72
2019
Q1 		$329K Hold
2,940
– – 0.06% 74
2018
Q4 		$284K Hold
2,940
– – 0.06% 75
2018
Q3 		$359K Hold
2,940
– – 0.06% 72
2018
Q2 		$323K Hold
2,940
– – 0.06% 74
2018
Q1 		$314K Hold
2,940
– – 0.06% 76
2017
Q4 		$314K Buy
2,940
+720
+32% +$77K 0.06% 77
2017
Q3 		$247K Buy
+2,220
New +$237K 0.05% 85

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jay A. Fishman Ltd's IBB Position: Q3 2025 in Review

Jay A. Fishman Ltd sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 2,940 shares — an estimated $372K sold.

Jay A. Fishman Ltd first reported a position in IBB in Q3 2017 and held it in 32 quarters. The position peaked at $645K in Q1 2020. 804 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Jay A. Fishman Ltd reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 2,940 iShares Biotechnology ETF shares in Q3 2025, an estimated $372K.
  • Jay A. Fishman Ltd first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 32 quarters.
  • Jay A. Fishman Ltd's iShares Biotechnology ETF position peaked at $645K in Q1 2020.
  • 804 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2025, filed 5 Nov 2025.